Rabbit Uterine Adenocarcinoma: Prevention, Diagnosis, Staging, and Treatment

At a Glance

Rabbit uterine adenocarcinoma is a malignant neoplasm of endometrial glandular epithelium that occurs primarily in intact female rabbits over three years of age. This condition represents the most common reproductive tract malignancy in domestic rabbits and is a leading cause of morbidity and mortality in unspayed does. The disease progresses from microscopic endometrial hyperplasia through carcinoma in situ to invasive adenocarcinoma with metastatic potential. Prevention through elective ovariohysterectomy before two years of age is the single most effective intervention. Clinical detection relies on owner observation of hematuria, abdominal palpation of masses, and diagnostic imaging. Surgical treatment by ovariohysterectomy offers curative potential when performed before metastasis occurs. Prognosis depends on tumor stage at the time of intervention.

Prevalence and Risk Factors

Uterine adenocarcinoma occurs with high frequency in intact female rabbits. The Merck Veterinary Manual identifies uterine adenocarcinoma as the most common neoplasm of the reproductive tract in female rabbits. Published case series document uterine disorders in a substantial proportion of pet rabbits presented for reproductive tract evaluation. A 2015 study in the Journal of the American Animal Hospital Association examined uterine disorders in 50 pet rabbits and documented the range of reproductive tract pathology encountered in clinical practice.

Risk increases with age, with most cases diagnosed in does over three years old. Breed predisposition has been suggested but not definitively established in controlled studies. The prolonged estrogen exposure from repeated estrous cycles in intact does is believed to drive neoplastic transformation of endometrial tissue.

Age at spaying directly influences risk. Rabbits spayed before two years of age have negligible risk of developing uterine adenocarcinoma. The protective effect of early ovariohysterectomy is well documented in veterinary literature. Delayed spaying after two years does not eliminate risk because neoplastic transformation may already have begun. The 2017 review in Veterinary Clinics of North America Exotic Animal Practice on rabbit oncology provides context for understanding the relationship between reproductive hormones and neoplastic development.

Pathophysiology and Disease Progression

Uterine adenocarcinoma arises from the endometrial epithelium. The disease follows a predictable progression from endometrial hyperplasia to carcinoma in situ to invasive adenocarcinoma. Hormonal influences, particularly prolonged estrogen exposure from repeated estrous cycles, are believed to drive neoplastic transformation. The rabbit uterus is anatomically unique, consisting of two separate uterine horns, a single cervix, and two cervices in some individuals. Tumors may develop in one or both horns.

Early lesions appear as focal thickening of the endometrium. As the tumor grows, it forms a sessile or pedunculated mass that projects into the uterine lumen. Invasion through the myometrium occurs with progressive disease. Metastatic spread follows lymphatic and hematogenous routes. Common metastatic sites include the lungs, liver, kidneys, and abdominal lymph nodes. Pulmonary metastasis is particularly common and may be detected on thoracic radiographs.

The time course from initiation to clinical detection varies. Some tumors remain confined to the uterus for months, while others metastasize early. The biologic behavior of individual tumors is difficult to predict based on histologic appearance alone. A 2011 case report in the Journal of the American Veterinary Medical Association described the diagnostic challenges and pathologic findings associated with uterine adenocarcinoma in a rabbit.

Clinical Signs and Owner Observations

Clinical signs of uterine adenocarcinoma are often subtle in early disease. Owners may notice no abnormalities until the tumor reaches substantial size or metastasizes. The most common presenting sign is hematuria. Owners frequently report red urine, which must be distinguished from normal porphyrin pigment excretion. True hematuria appears as frank blood or blood clots in the urine, while porphyrinuria produces a uniform reddish-orange discoloration.

Abdominal distension develops as the uterine mass enlarges. Owners may report a firm, palpable mass in the caudal abdomen. Affected rabbits may show reduced appetite, weight loss, lethargy, or hunched posture. Dysuria or tenesmus can occur if the mass compresses the urinary tract or colon. Vaginal discharge, when present, is often bloody or serosanguinous.

Respiratory signs such as dyspnea, tachypnea, or open-mouth breathing may indicate pulmonary metastasis. Owners should be questioned about coughing, exercise intolerance, or changes in respiratory pattern. Neurologic signs are uncommon but can occur with metastasis to the central nervous system.

Owner Observation Checklist

Veterinarians should instruct owners to monitor for the following signs and report them promptly:

Blood in urine that appears as frank blood or clots instead of uniform discoloration

A firm lump or swelling in the lower abdomen

Decreased appetite or weight loss over weeks to months

Labored breathing, rapid breathing, or open-mouth breathing

Lethargy or reduced activity level

Straining to urinate or defecate

Bloody discharge from the vulva

Diagnostic Imaging

Abdominal Ultrasound

Abdominal ultrasound is the imaging modality of choice for evaluating the rabbit reproductive tract. The procedure requires a high-frequency transducer, typically 7.5 to 12 MHz, and careful patient positioning. The rabbit is placed in dorsal recumbency after manual restraint or sedation. The urinary bladder is identified as a landmark, and the uterine horns are located dorsal to the bladder.

Normal uterine horns appear as thin-walled tubular structures with a homogeneous echogenic lumen. The uterine wall thickness in non-gravid does is typically less than 2 mm. In uterine adenocarcinoma, the affected horn appears enlarged with a thickened, irregular wall. The tumor mass may appear as a hypoechoic or mixed echogenicity lesion projecting into the lumen. Cystic areas within the mass suggest necrosis or hemorrhage.

Ultrasound allows assessment of tumor size, location, and extent of uterine wall invasion. The contralateral horn should be examined for synchronous lesions. Abdominal lymph nodes, particularly the iliac and lumbar nodes, should be evaluated for enlargement or abnormal echogenicity. The liver and kidneys should be scanned for metastatic lesions.

Radiography

Three-view thoracic radiographs are indicated to evaluate for pulmonary metastasis. The rabbit is positioned in right lateral, left lateral, and ventrodorsal projections. Pulmonary metastases appear as well-defined nodular opacities distributed throughout the lung fields. The nodules may be single or multiple and vary in size from a few millimeters to several centimeters.

Abdominal radiographs may reveal a soft tissue mass in the caudal abdomen. The mass may displace the intestinal loops cranially or laterally. Mineralization within the tumor is uncommon but can occur. Radiographic signs of metastasis to other abdominal organs are often absent until advanced disease.

Computed Tomography

Computed tomography provides superior anatomic detail compared to ultrasound and radiography. CT allows precise assessment of tumor size, local invasion, and regional lymph node involvement. Thoracic CT is more sensitive than radiography for detecting small pulmonary metastases. The procedure requires general anesthesia and specialized equipment, limiting its availability to referral centers.

Diagnostic Imaging Protocol

Staging and Prognostic Assessment

Staging of uterine adenocarcinoma follows the World Organisation for Animal Health guidelines for animal health and welfare. The staging system is based on tumor extent, lymph node involvement, and presence of distant metastasis. Accurate staging requires complete diagnostic imaging and histopathologic evaluation of surgical specimens.

Stage I tumors are confined to the endometrium without myometrial invasion. Stage II tumors invade the myometrium but remain within the uterine serosa. Stage III tumors extend beyond the uterus into adjacent tissues or involve regional lymph nodes. Stage IV tumors have distant metastasis to lungs, liver, or other organs.

Prognosis correlates strongly with stage at diagnosis. Rabbits with Stage I or II disease treated by complete ovariohysterectomy have a good prognosis for long-term survival. Stage III disease carries a guarded prognosis, with recurrence or progression possible despite surgery. Stage IV disease has a poor prognosis, and treatment is primarily palliative.

Histologic grading provides additional prognostic information. Well-differentiated tumors with low mitotic activity have a better prognosis than poorly differentiated tumors with high mitotic activity. The presence of vascular or lymphatic invasion indicates aggressive biologic behavior.

Staging Classification

Surgical Treatment

Ovariohysterectomy

Complete ovariohysterectomy is the definitive treatment for uterine adenocarcinoma. The procedure involves removal of both ovaries, both uterine horns, the uterine body, and the cervix. The surgical approach is through a ventral midline celiotomy. The rabbit is positioned in dorsal recumbency, and the abdomen is clipped and aseptically prepared.

The ovarian pedicles are ligated with absorbable suture material. The uterine body is ligated just cranial to the cervix, and the entire reproductive tract is removed. Care must be taken to avoid rupture of the uterine mass during manipulation. The abdomen is closed in three layers: muscle, subcutaneous tissue, and skin.

Regional lymph nodes should be sampled for histopathologic evaluation. The iliac and lumbar lymph nodes are most commonly involved. Enlarged or abnormal-appearing nodes should be excised. Normal-appearing nodes may be sampled for staging purposes.

A 1998 case report in The Veterinary Record documented successful treatment of a uterine adenocarcinoma in a domestic rabbit by ovariohysterectomy, demonstrating the curative potential of surgical intervention when disease is confined to the uterus.

Perioperative Considerations

Rabbits with uterine adenocarcinoma may have concurrent medical conditions that affect anesthetic risk. Preoperative evaluation should include complete blood count, serum biochemistry, and thoracic radiographs. Rabbits with pulmonary metastasis may have reduced respiratory reserve and require careful anesthetic management.

Pain management is essential. Multimodal analgesia using opioids, nonsteroidal anti-inflammatory drugs, and local anesthetics is recommended. The choice of analgesic agents should consider renal and hepatic function.

Postoperative monitoring includes assessment of appetite, fecal output, and urine production. Rabbits should be offered their normal diet as soon as they recover from anesthesia. Syringe feeding may be necessary if appetite is reduced. Incision care involves keeping the surgical site clean and dry. Elizabethan collars are rarely tolerated by rabbits and should be used only when necessary.

Surgical Outcomes

Published case reports document successful treatment of uterine adenocarcinoma by ovariohysterectomy. Rabbits with disease confined to the uterus at the time of surgery have a good prognosis for long-term survival. Recurrence after complete excision is uncommon. Rabbits with metastatic disease at the time of surgery may experience temporary improvement but ultimately succumb to progressive disease.

Surgical Decision Framework

Medical Management Options

Hormonal Therapy

Hormonal therapy has been investigated for treatment of uterine adenocarcinoma in rabbits. Progestins such as megestrol acetate have been used in other species for endometrial cancer treatment. The published literature on megestrol acetate clinical experience in rabbits is limited. A 1989 review in Cancer Treatment Reviews examined clinical experience with megestrol acetate across species. Hormonal therapy is considered a palliative option for rabbits that are not surgical candidates.

COX-2 Inhibitors

Cyclooxygenase-2 expression has been investigated in rabbit uterine adenocarcinoma. A 2024 study published in Animals examined immunohistochemical expression of COX-2 in rabbit uterine adenocarcinoma tissue. The study suggested potential use of COX-2 inhibitors in cancer therapy. Clinical application of COX-2 inhibitors for treatment of uterine adenocarcinoma in rabbits requires further investigation. These agents are not currently standard of care.

Chemotherapy

Chemotherapy for rabbit uterine adenocarcinoma is not well established. Published literature on chemotherapy protocols for this condition is limited to case reports and small case series. The toxicity profile of chemotherapeutic agents in rabbits differs from that in dogs and cats. Chemotherapy is generally reserved for rabbits with metastatic disease that cannot be surgically excised.

Prevention Through Elective Spaying

Elective ovariohysterectomy before two years of age is the most effective preventive measure against uterine adenocarcinoma. The procedure eliminates the hormonal environment that drives neoplastic transformation. Rabbits spayed before two years have negligible risk of developing uterine adenocarcinoma.

The optimal age for elective spaying is between four and six months. At this age, rabbits are sexually mature but have not yet experienced prolonged estrogen exposure. Spaying before four months is technically feasible but carries increased anesthetic risk due to small patient size. Spaying after six months is still preventive but allows more time for neoplastic changes to begin.

Owner education about the benefits of early spaying is essential. Many owners are unaware of the high prevalence of uterine adenocarcinoma in intact does. Veterinarians should discuss the risks and benefits of spaying during routine wellness examinations. The procedure should be presented as a preventive health measure instead of an optional surgery.

Owner Education Points

Uterine adenocarcinoma affects a large proportion of intact female rabbits over three years of age

Spaying before two years of age effectively eliminates this risk

The procedure also prevents unwanted pregnancy, uterine infections, and other reproductive tract diseases

Anesthetic risk in healthy young rabbits is low with appropriate protocols

Recovery from spaying is typically rapid, with rabbits returning to normal activity within days

Differential Diagnoses

Several conditions can mimic uterine adenocarcinoma in rabbits. Endometrial hyperplasia is a benign proliferation of endometrial glands that can produce similar ultrasound findings. Endometrial hyperplasia is considered a precursor lesion to adenocarcinoma and may coexist with malignant change.

Endometritis and pyometra can cause uterine enlargement and vaginal discharge. These conditions are typically associated with bacterial infection. Pasteurella multocida is a common cause of reproductive tract infection in rabbits. The Merck Veterinary Manual identifies pasteurellosis as a significant disease in rabbits. A 2023 review in Veterinarska Stanica examined pasteurellosis as a significant bacterial disease in rabbit production, and a 2013 article in Large Animal Review addressed control of reproductive disease caused by Pasteurella species in rabbits.

Uterine leiomyoma is a benign smooth muscle tumor that can produce a uterine mass. Leiomyomas are less common than adenocarcinomas in rabbits. Differentiation requires histopathologic evaluation.

Vaginal or cervical neoplasia can produce similar clinical signs. These tumors are less common than uterine adenocarcinoma. Diagnostic imaging and biopsy are necessary for definitive diagnosis.

A 2018 article in Kleintierpraxis examined changes of the uterus in rabbits, providing context for differentiating benign from malignant uterine pathology.

Differential Diagnosis Table

Common Failure Patterns

Delayed Diagnosis

The most common failure pattern in managing rabbit uterine adenocarcinoma is delayed diagnosis. Owners often attribute hematuria to normal porphyrin excretion and delay veterinary evaluation. By the time clinical signs are recognized, the tumor may have reached advanced stage. Routine screening of intact does over three years old can reduce diagnostic delay.

Incomplete Surgical Excision

Incomplete surgical excision occurs when tumor tissue is left behind during ovariohysterectomy. This can happen if the uterine mass is ruptured during manipulation, if the cervix is not completely removed, or if metastatic lesions are not identified. Careful surgical technique and thorough abdominal exploration reduce the risk of incomplete excision.

Missed Metastasis

Pulmonary metastasis may be missed on thoracic radiographs if lesions are small or located in areas obscured by overlying structures. Thoracic CT is more sensitive for detecting small metastases. Rabbits with normal radiographs may still have microscopic metastatic disease.

Owner Noncompliance

Owner noncompliance with recommended screening or treatment contributes to poor outcomes. Some owners decline spaying due to cost concerns or perceived risks. Others delay evaluation of clinical signs. Clear communication about the benefits of early intervention improves compliance.

Failure to Sample Lymph Nodes

Skipping lymph node sampling during ovariohysterectomy results in incomplete staging. Without lymph node histopathology, the presence of regional metastasis may go undetected, leading to inaccurate prognosis and inadequate follow-up planning.

Records and Measurements

Accurate medical records are essential for managing rabbits with uterine adenocarcinoma. The following information should be documented:

Patient signalment: species, breed, age, sex, reproductive status, weight.

Clinical history: onset and duration of clinical signs, previous reproductive events, concurrent medical conditions.

Physical examination findings: body condition score, abdominal palpation findings, vaginal examination findings.

Diagnostic imaging findings: ultrasound measurements of uterine horns and masses, radiographic findings, CT findings if performed.

Surgical findings: tumor location, size, extent of invasion, lymph node appearance, presence of metastatic lesions.

Histopathologic findings: tumor type, grade, depth of invasion, lymphovascular invasion, lymph node status.

Postoperative monitoring: recovery from anesthesia, appetite, fecal output, incision healing, long-term follow-up.

Recommended Record Template

Welfare and Safety Context

Uterine adenocarcinoma causes significant welfare compromise in affected rabbits. Pain from tumor growth, dysuria from urinary tract compression, and dyspnea from pulmonary metastasis all reduce quality of life. Early detection and treatment improve welfare outcomes.

Anesthetic safety is a concern in rabbits with advanced disease. Rabbits with pulmonary metastasis have reduced respiratory reserve and are at increased risk of anesthetic complications. Preoperative stabilization and careful anesthetic monitoring are essential.

Surgical safety requires attention to hemostasis and tissue handling. The rabbit uterus is friable and easily ruptured. Gentle tissue handling and careful ligation of vascular peduncles reduce the risk of hemorrhage.

The World Organisation for Animal Health provides guidelines for animal health and welfare that apply to the management of reproductive disease in production and companion animals. These guidelines emphasize the importance of preventive healthcare, early disease detection, and humane treatment.

Welfare Assessment Points

Monitor for signs of pain: hunched posture, teeth grinding, reduced appetite, decreased activity

Assess respiratory effort and rate before and after treatment

Evaluate quality of life using standardized scoring systems for rabbits with chronic disease

Provide appropriate analgesia during all stages of diagnosis and treatment

Consider euthanasia when quality of life is unacceptable due to progressive disease

Professional Escalation Criteria

Veterinarians should consider referral to a specialist in the following situations:

Large or invasive tumors that require advanced surgical techniques.

Suspected metastatic disease that requires CT imaging for accurate staging.

Rabbits with concurrent medical conditions that complicate anesthetic management.

Cases where owner communication about prognosis or treatment options is challenging.

Recurrent disease after previous surgical treatment.

Uncertainty about histopathologic interpretation of biopsy specimens.

Need for advanced imaging modalities not available in general practice.

When to Refer

Practical Decision Framework for Post-Surgical Monitoring and Long-Term Surveillance

Effective management of rabbit uterine adenocarcinoma extends beyond the surgical procedure itself. A structured post-surgical monitoring and surveillance program is essential for detecting recurrence, managing complications, and optimizing long-term outcomes. This section provides a practical decision framework for veterinarians managing rabbits after ovariohysterectomy for uterine adenocarcinoma, including specific monitoring protocols, record-keeping systems, and escalation criteria.

Post-Surgical Monitoring Protocol

The immediate post-operative period requires systematic assessment of recovery parameters. Rabbits should be evaluated at 12, 24, and 48 hours after surgery for appetite, fecal output, urine production, and incision integrity. The Merck Veterinary Manual emphasizes that rabbits are obligate nasal breathers and stress-sensitive, making careful monitoring of respiratory rate and behavior essential during recovery.

Day 1 to 3 Monitoring Checklist

Long-Term Surveillance Schedule

Rabbits treated for uterine adenocarcinoma require ongoing surveillance to detect recurrence or metastatic progression. The surveillance schedule should be tailored to the stage at diagnosis and histologic grade of the tumor.

Stage-Based Surveillance Protocol

Stage I Disease (Confined to Endometrium)

Physical examination and abdominal palpation every 6 months for the first 2 years, then annually thereafter. Abdominal ultrasound at 6 months and 12 months post-surgery, then annually if no abnormalities detected. Thoracic radiographs at 12 months post-surgery, then annually for 3 years. The 2017 review in Veterinary Clinics of North America Exotic Animal Practice on rabbit oncology supports this approach for early-stage disease with complete surgical excision.

Stage II Disease (Myometrial Invasion)

Physical examination and abdominal palpation every 3 months for the first year, then every 6 months for the second year, then annually. Abdominal ultrasound every 6 months for the first 2 years, then annually. Thoracic radiographs every 6 months for the first 2 years, then annually. Consider thoracic CT at 12 months post-surgery for baseline comparison.

Stage III Disease (Regional Lymph Node Involvement)

Physical examination and abdominal palpation every 2 to 3 months for the first 2 years, then every 6 months. Abdominal ultrasound every 3 to 4 months for the first year, then every 6 months. Thoracic radiographs every 3 to 4 months for the first year, then every 6 months. Thoracic CT every 6 to 12 months for the first 2 years. Consider referral to a veterinary oncologist for adjuvant therapy options.

Stage IV Disease (Distant Metastasis)

Physical examination and quality of life assessment every 1 to 2 months. Abdominal ultrasound and thoracic radiographs every 2 to 3 months to monitor progression. Focus on palliative care and quality of life maintenance. The World Organisation for Animal Health guidelines for animal health and welfare emphasize humane endpoints and euthanasia consideration when quality of life deteriorates.

Record System for Surveillance Data

Accurate longitudinal records enable detection of subtle changes that may indicate recurrence or progression. The following record system organizes surveillance data for clinical decision-making.

Surveillance Record Template

Scoring System Definitions

Body Condition Score (BCS): 1-9 scale where 1 is emaciated, 5 is ideal, 9 is obese. The Merck Veterinary Manual provides species-specific BCS guidelines for rabbits.

Pain Score: 0 = no pain (normal grooming, alert, interactive), 1 = mild pain (slightly hunched, reduced activity), 2 = moderate pain (hunched posture, teeth grinding, reduced appetite), 3 = severe pain (immobile, anorexia, vocalization).

Appetite Score: 0 = normal eating, 1 = reduced but eating some, 2 = eating only preferred foods, 3 = anorexia requiring syringe feeding.

Activity Score: 0 = normal activity, 1 = slightly reduced, 2 = significantly reduced, 3 = recumbent or minimally active.

Common Failure Patterns in Post-Surgical Management

Failure Pattern 1: Inadequate Baseline Imaging

The most common failure pattern is performing surgery without complete preoperative staging. Without thoracic radiographs or CT before surgery, the presence of pulmonary metastasis may go undetected. This leads to inaccurate prognosis and inappropriate surveillance planning. A 2011 case report in the Journal of the American Veterinary Medical Association described the diagnostic challenges when preoperative imaging is incomplete.

Prevention Protocol: Obtain three-view thoracic radiographs and abdominal ultrasound before any ovariohysterectomy for suspected uterine adenocarcinoma. Document findings in the medical record before proceeding with surgery.

Failure Pattern 2: Incomplete Lymph Node Sampling

Skipping lymph node sampling during ovariohysterectomy results in understaging. Without histopathologic evaluation of regional lymph nodes, Stage III disease may be misclassified as Stage I or II. This leads to inadequate surveillance and missed opportunities for early intervention.

Prevention Protocol: During ovariohysterectomy, identify and sample the iliac and lumbar lymph nodes. Submit all sampled nodes for histopathologic evaluation. Document the number and location of nodes sampled in the surgical report.

Failure Pattern 3: Inconsistent Follow-Up Intervals

Owners may miss scheduled recheck appointments, leading to delayed detection of recurrence. The 2015 study in the Journal of the American Animal Hospital Association on uterine disorders in 50 pet rabbits highlighted that inconsistent follow-up contributed to poor outcomes in some cases.

Prevention Protocol: Provide owners with a written surveillance schedule at the time of discharge. Schedule the first recheck appointment before the rabbit leaves the hospital. Send reminder notifications for subsequent appointments. Document missed appointments and attempt to reschedule within 2 weeks.

Failure Pattern 4: Failure to Recognize Recurrence Signs

Owners may attribute recurrent hematuria, abdominal distension, or respiratory signs to other causes. Without prompt veterinary evaluation, recurrence may progress to advanced stage before detection.

Prevention Protocol: Educate owners about specific signs of recurrence at the time of discharge. Provide a written list of signs that require immediate veterinary evaluation. Include contact information for emergency services.

Troubleshooting Method for Surveillance Abnormalities

When surveillance detects an abnormality, a systematic troubleshooting approach guides clinical decision-making.

Step 1: Confirm the Abnormality

Repeat the abnormal finding to confirm it is not an artifact. For ultrasound findings, resean the area with a different transducer angle or frequency. For radiographic findings, obtain additional views if needed. For physical examination findings, have a second clinician palpate the area.

Step 2: Characterize the Abnormality

Document the location, size, shape, echogenicity, and vascularity of any new mass or lesion. Compare with previous imaging studies to determine if the finding is new or progressive. Measure and photograph the finding for objective documentation.

Step 3: Determine Clinical Significance

Consider the stage at initial diagnosis, histologic grade, and time since surgery. A new 2 mm pulmonary nodule detected 6 months after surgery for Stage I disease is more concerning than the same finding 3 years after surgery. The 2017 review in Veterinary Clinics of North America Exotic Animal Practice provides context for interpreting surveillance findings based on tumor biology.

Step 4: Develop a Diagnostic Plan

Based on the clinical significance assessment, develop a diagnostic plan. Options include:

Short-term recheck in 4 to 6 weeks to assess progression

Advanced imaging (CT, MRI) for better characterization

Ultrasound-guided fine needle aspiration or biopsy

Referral to a specialist for further evaluation

Step 5: Implement and Document

Perform the recommended diagnostic tests and document all findings. Update the surveillance record with the new information. Adjust the surveillance schedule based on the results.

Decision Matrix for Surveillance Abnormalities

Welfare and Safety Context for Surveillance

Surveillance procedures carry their own welfare implications. Repeated handling, restraint, and diagnostic procedures can cause stress in rabbits. The World Organisation for Animal Health guidelines for animal health and welfare emphasize minimizing stress during veterinary procedures.

Stress Reduction Strategies

Use towel wrapping or rabbit-specific restraint techniques during handling

Minimize time in dorsal recumbency for ultrasound examinations

Use sedation when necessary for prolonged or invasive procedures

Provide familiar bedding or hiding boxes in the examination room

Schedule procedures during the rabbit's active periods (dawn and dusk)

Offer favorite foods after procedures as positive reinforcement

Quality of Life Assessment

At each surveillance visit, assess quality of life using a standardized scoring system. The following parameters should be evaluated:

Appetite and food intake

Fecal output and consistency

Urination pattern

Activity level and interaction with environment

Grooming behavior

Pain indicators (hunched posture, teeth grinding, reduced activity)

Owner-reported quality of life

When quality of life deteriorates despite treatment, discuss humane euthanasia options with the owner. The World Organisation for Animal Health guidelines emphasize that euthanasia should be performed by a veterinarian using humane methods when continued life results in unacceptable suffering.

Professional Escalation Criteria for Surveillance Findings

Veterinarians should consider referral to a specialist when surveillance detects the following:

New metastatic lesions that require advanced imaging for characterization

Recurrent disease that may benefit from adjuvant therapy

Progressive disease despite appropriate surgical treatment

Diagnostic uncertainty requiring specialist interpretation

Owner communication challenges regarding prognosis or treatment options

Need for advanced therapeutic interventions not available in general practice

When to Refer During Surveillance

Summary of Practical Implementation Steps

1. Develop a written surveillance protocol for each rabbit based on stage at diagnosis
2. Create a surveillance record template for longitudinal data collection
3. Educate owners about signs of recurrence and the importance of consistent follow-up
4. Schedule the first recheck appointment before discharge
5. Use a systematic troubleshooting approach for surveillance abnormalities
6. Document all findings and update the surveillance schedule as needed
7. Refer to specialists when findings exceed general practice capabilities
8. Assess quality of life at each surveillance visit
9. Discuss humane endpoints when quality of life deteriorates
10. Maintain accurate records for clinical decision-making and outcome assessment

Frequently Asked Questions

What is the prevalence of uterine adenocarcinoma in intact female rabbits?

Uterine adenocarcinoma is the most common reproductive tract malignancy in female rabbits. The Merck Veterinary Manual identifies it as the most common neoplasm of the reproductive tract in this species. Prevalence increases with age, with most cases diagnosed in does over three years old. Published case series document uterine disorders in a substantial proportion of pet rabbits presented for reproductive tract evaluation.

Can uterine adenocarcinoma be prevented by spaying?

Yes, elective ovariohysterectomy before two years of age effectively prevents uterine adenocarcinoma. The procedure eliminates the hormonal environment that drives neoplastic transformation. Rabbits spayed before two years have negligible risk of developing this condition. Spaying after two years reduces risk but does not eliminate it because neoplastic changes may already have begun.

What are the early signs of uterine adenocarcinoma in rabbits?

The most common early sign is hematuria, which owners may mistake for normal porphyrin pigment excretion. True hematuria appears as frank blood or blood clots in the urine. Other early signs include abdominal distension, a palpable mass in the caudal abdomen, reduced appetite, weight loss, and lethargy. Vaginal discharge may be present. Respiratory signs such as dyspnea may indicate pulmonary metastasis.

How is uterine adenocarcinoma diagnosed in rabbits?

Diagnosis begins with a thorough history and physical examination. Abdominal ultrasound is the imaging modality of choice for evaluating the reproductive tract. Three-view thoracic radiographs are indicated to evaluate for pulmonary metastasis. Computed tomography provides superior anatomic detail and is more sensitive for detecting small metastases. Definitive diagnosis requires histopathologic evaluation of surgical specimens.

What is the treatment for uterine adenocarcinoma in rabbits?

Complete ovariohysterectomy is the definitive treatment. The procedure involves removal of both ovaries, both uterine horns, the uterine body, and the cervix. Regional lymph nodes should be sampled for staging. Rabbits with disease confined to the uterus at the time of surgery have a good prognosis for long-term survival. Medical management options including hormonal therapy and COX-2 inhibitors are under investigation but are not standard of care.

What is the prognosis for rabbits with uterine adenocarcinoma?

Prognosis depends on tumor stage at diagnosis. Rabbits with Stage I or II disease treated by complete ovariohysterectomy have a good prognosis for long-term survival. Stage III disease carries a guarded prognosis, with recurrence or progression possible despite surgery. Stage IV disease has a poor prognosis, and treatment is primarily palliative. Histologic grade and presence of vascular invasion also influence prognosis.

Can uterine adenocarcinoma metastasize to other organs?

Yes, uterine adenocarcinoma metastasizes through lymphatic and hematogenous routes. Common metastatic sites include the lungs, liver, kidneys, and abdominal lymph nodes. Pulmonary metastasis is particularly common and may be detected on thoracic radiographs. Accurate staging requires evaluation for metastatic disease before surgical treatment.

When should I refer a rabbit with uterine adenocarcinoma to a specialist?

Referral to a specialist is indicated for large or invasive tumors requiring advanced surgical techniques, suspected metastatic disease requiring CT imaging, rabbits with concurrent medical conditions complicating anesthetic management, cases where owner communication about prognosis or treatment options is challenging, and recurrent disease after previous surgical treatment.

Related Veterinary Guides

• Equine Dental Conditions Diagnosis Treatment
• Rabbit Dental Spurs
• Rabbit Dental Disease
• Pet Dental Disease Signs
• Rabbit Preventive Care Wellness Exams

References and Further Reading

• www.merckvetmanual.com
• www.avma.org
• www.aemv.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Immunohistochemical Investigation of Cyclooxygenase-2 Expression in Rabbit Uterine Adenocarcinoma and the Potential Use of COX-2 Inhibitors in Cancer Therapy.. Animals : an open access journal from MDPI, 2024.
• Treatment of a uterine adenocarcinoma in a domestic rabbit by ovariohysterectomy.. The Veterinary record, 1998.
• Rabbit Oncology: Diseases, Diagnostics, and Therapeutics.. The veterinary clinics of North America. Exotic animal practice, 2017.
• What is your diagnosis? Uterine adenocarcinoma.. Journal of the American Veterinary Medical Association, 2011.
• Megestrol acetate: clinical experience.. Cancer treatment reviews, 1989.
• Uterine disorders in 50 pet rabbits.. Journal of the American Animal Hospital Association, 2015.
• Pasteurellosis: A significant bacterial disease in rabbit production. Veterinarska Stanica, 2023.
• Control of disease of reproductive Pasteurella spp rabbit. Large Animal Review, 2013.
• Changes of the uterus in the rabbit. Kleintierpraxis, 2018.
• Abortion, stillbirth, neonatal death, and nutritional myodegeneration in a rabbit breeding colony.. Journal of the American Veterinary Medical Association, 1989.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.